Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
Hims & Hers surges 4% as peptide policy shift unlocks growth
10:42am, Thursday, 16'th Apr 2026
Shares of Hims & Hers Health moved sharply higher on Thursday, extending gains from the previous session after a significant regulatory shift signaled new opportunities in the peptide market. The stoc
BofA Raises Hims & Hers Target to $25 as FDA Takes a Step Toward Wellness Peptides: Is a New Revenue Boom Coming?
10:34am, Thursday, 16'th Apr 2026
Hims & Hers Health (NYSE:HIMS) just got a fresh look from Bank of America, which raised its price target on the stock to $25 from $21 while maintaining a Neutral rating.
Hims & Hers Stock Stays Hot Amid Peptides Buzz
10:18am, Thursday, 16'th Apr 2026
Hims & Hers Health Inc (NYSE:HIMS) is one of the best performing stocks on the New York Stock Exchange (NYSE) today, up 4.5% to trade at $25.52.
Hims & Hers shares jump as FDA begins review of restricted peptide compounds
09:12am, Thursday, 16'th Apr 2026
Shares of Hims & Hers Health (NYSE:HIMS) rose more than 8% to about $26 after the US Food and Drug Administration (FDA) moved to begin a formal review...
Hims & Hers Health Stock Rallies on Regulatory Pivot. It's Not About GLP-1s This Time.
08:46am, Thursday, 16'th Apr 2026
Hims has signaled its interest in peptides, many of which have been banned for use in compounding pharmacies.
FDA Peptide Review, A Big Moment For Hims & Hers (Rating Upgrade)
08:09am, Thursday, 16'th Apr 2026
Hims & Hers faces a pivotal regulatory moment as the FDA reconsiders compounded peptide therapies, especially GLP-1 drugs like semaglutide. A permissive FDA framework could legitimize compounded pepti
Hims Gains as Peptide Policy Shift Takes Shape
07:54am, Thursday, 16'th Apr 2026
Hims and Hers Health (HIMS) shares climbed 6.88% in premarket trading, building on a 13.72% gain from Wednesday's session, after Health and Human Services Secreta
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
05:39pm, Wednesday, 15'th Apr 2026
Hims & Hers Health's plan to enter the business of selling peptides is looking a lot more realistic.
Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes
05:58pm, Tuesday, 14'th Apr 2026
Hims & Hers has sharply declined, losing nearly 40% YTD and two-thirds from last year's peak. Despite the selloff, I see compelling value in HIMS at its current, compressed valuation. Markets have pen
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms
10:50am, Tuesday, 14'th Apr 2026
HIMS unites telehealth, records and pharmacy fulfillment on one digital platform, adding AI tools, diagnostics and FDA-approved medicines.
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Tuesday, 14'th Apr 2026
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
04:05pm, Monday, 13'th Apr 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial res
Did Hims & Hers Just Become an AI Company?
07:57am, Friday, 10'th Apr 2026
Hims & Hers announced its strategy around AI and how it fits into the company's platform. AI could enable more products and solutions for users outside of traditional prescriptions.
Oluyemi Okupe Sells 3,975 Shares of Hims & Hers Health (NYSE:HIMS) Stock
04:54am, Thursday, 09'th Apr 2026
Hims and Hers Health, Inc. (NYSE: HIMS - Get Free Report) CFO Oluyemi Okupe sold 3,975 shares of the stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price o
Hims & Hers price target slashed amid GLP-1 transition
12:26pm, Wednesday, 08'th Apr 2026
Bank of America lowered its 2026 price target for Hims & Hers (NYSE:HIMS) to $21 from $23, citing peer multiple compression and near-term earnings pressures. Shares of Hims & Hers traded hands at abou
